Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
-
Published:2021-12-23
Issue:1
Volume:6
Page:88-102
-
ISSN:2397-334X
-
Container-title:Nature Ecology & Evolution
-
language:en
-
Short-container-title:Nat Ecol Evol
Author:
Fu XiaoORCID, Zhao YueORCID, Lopez Jose I., Rowan Andrew, Au Lewis, Fendler AnnikaORCID, Hazell Steve, Xu HangORCID, Horswell Stuart, Shepherd Scott T. C.ORCID, Spencer Charlotte E., Spain Lavinia, Byrne FionaORCID, Stamp GordonORCID, O’Brien Tim, Nicol David, Augustine Marcellus, Chandra Ashish, Rudman Sarah, Toncheva Antonia, Furness Andrew J. S., Pickering LisaORCID, Kumar SantoshORCID, Koh Dow-Mu, Messiou ChristinaORCID, Dafydd Derfel ap, Orton Matthew R., Doran Simon J.ORCID, Larkin James, Swanton CharlesORCID, Sahai ErikORCID, Litchfield KevinORCID, Turajlic SamraORCID, Ben Challacombe , Chowdhury Simon, Drake William, Fernando Archana, Fotiadis Nicos, Hatipoglu Emine, Harrison-Phipps Karen, Hill Peter, Horsfield Catherine, Marafioti Teresa, Olsburgh Jonathon, Polson Alexander, Quezada Sergio, Varia Mary, Verma Hema, Bates Paul A.ORCID,
Abstract
AbstractGenetic intra-tumour heterogeneity fuels clonal evolution, but our understanding of clinically relevant clonal dynamics remain limited. We investigated spatial and temporal features of clonal diversification in clear cell renal cell carcinoma through a combination of modelling and real tumour analysis. We observe that the mode of tumour growth, surface or volume, impacts the extent of subclonal diversification, enabling interpretation of clonal diversity in patient tumours. Specific patterns of proliferation and necrosis explain clonal expansion and emergence of parallel evolution and microdiversity in tumours. In silico time-course studies reveal the appearance of budding structures before detectable subclonal diversification. Intriguingly, we observe radiological evidence of budding structures in early-stage clear cell renal cell carcinoma, indicating that future clonal evolution may be predictable from imaging. Our findings offer a window into the temporal and spatial features of clinically relevant clonal evolution.
Funder
Cancer Research UK Wellcome Trust RCUK | Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
Ecology,Ecology, Evolution, Behavior and Systematics
Reference40 articles.
1. Merlo, L. M. F., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924–935 (2006). 2. Zahir, N., Sun, R., Gallahan, D., Gatenby, R. A. & Curtis, C. Characterizing the ecological and evolutionary dynamics of cancer. Nat. Genet. 52, 759–767 (2020). 3. McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613–628 (2017). 4. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012). 5. Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|